Investigating the potential anticancer activities of antibiotics as topoisomerase II inhibitors and DNA intercalators: in vitro, molecular docking, molecular dynamics, and SAR studies

Topoisomerase II (TOP-2) is a promising molecular target for cancer therapy. Numerous antibiotics could interact with biologically relevant macromolecules and provoke antitumor potential. Herein, molecular docking studies were used to investigate the binding interactions of 138 antibiotics against t...

Full description

Bibliographic Details
Main Authors: Faten Farouk, Ayman Abo Elmaaty, Ahmed Elkamhawy, Haytham O. Tawfik, Radwan Alnajjar, Mohammed A. S. Abourehab, Mohamed A. Saleh, Wagdy M. Eldehna, Ahmed A. Al‐Karmalawy
Format: Article
Language:English
Published: Taylor & Francis Group 2023-12-01
Series:Journal of Enzyme Inhibition and Medicinal Chemistry
Subjects:
Online Access:https://www.tandfonline.com/doi/10.1080/14756366.2023.2171029
_version_ 1827123360564248576
author Faten Farouk
Ayman Abo Elmaaty
Ahmed Elkamhawy
Haytham O. Tawfik
Radwan Alnajjar
Mohammed A. S. Abourehab
Mohamed A. Saleh
Wagdy M. Eldehna
Ahmed A. Al‐Karmalawy
author_facet Faten Farouk
Ayman Abo Elmaaty
Ahmed Elkamhawy
Haytham O. Tawfik
Radwan Alnajjar
Mohammed A. S. Abourehab
Mohamed A. Saleh
Wagdy M. Eldehna
Ahmed A. Al‐Karmalawy
author_sort Faten Farouk
collection DOAJ
description Topoisomerase II (TOP-2) is a promising molecular target for cancer therapy. Numerous antibiotics could interact with biologically relevant macromolecules and provoke antitumor potential. Herein, molecular docking studies were used to investigate the binding interactions of 138 antibiotics against the human topoisomerase II-DNA complex. Followed by the MD simulations for 200 ns and MM-GBSA calculations. On the other hand, the antitumor activities of the most promising candidates were investigated against three cancer cell lines using doxorubicin (DOX) as a reference drug. Notably, spiramycin (SP) and clarithromycin (CL) showed promising anticancer potentials on the MCF-7 cell line. Moreover, azithromycin (AZ) and CL exhibited good anticancer potentials against the HCT-116 cell line. Finally, the TOP-2 enzyme inhibition assay was carried out to confirm the proposed rationale. Briefly, potent TOP-2 inhibitory potentials were recorded for erythromycin (ER) and roxithromycin (RO). Additionally, a SAR study opened eyes to promising anticancer pharmacophores encountered by these antibiotics.
first_indexed 2024-03-09T02:03:02Z
format Article
id doaj.art-a1c855bf5ade4c9380cb028408c47807
institution Directory Open Access Journal
issn 1475-6366
1475-6374
language English
last_indexed 2025-03-20T14:23:41Z
publishDate 2023-12-01
publisher Taylor & Francis Group
record_format Article
series Journal of Enzyme Inhibition and Medicinal Chemistry
spelling doaj.art-a1c855bf5ade4c9380cb028408c478072024-09-09T17:23:19ZengTaylor & Francis GroupJournal of Enzyme Inhibition and Medicinal Chemistry1475-63661475-63742023-12-0138110.1080/14756366.2023.2171029Investigating the potential anticancer activities of antibiotics as topoisomerase II inhibitors and DNA intercalators: in vitro, molecular docking, molecular dynamics, and SAR studiesFaten Farouk0Ayman Abo Elmaaty1Ahmed Elkamhawy2Haytham O. Tawfik3Radwan Alnajjar4Mohammed A. S. Abourehab5Mohamed A. Saleh6Wagdy M. Eldehna7Ahmed A. Al‐Karmalawy8Pharmaceutical Chemistry Department, Faculty of Pharmacy, Ahram Canadian University, Giza, EgyptDepartment of Medicinal Chemistry, Faculty of Pharmacy, Port Said University, Port Said, EgyptBK21 FOUR Team and Integrated Research Institute for Drug Development, College of Pharmacy, Dongguk University-Seoul, Goyang, Republic of KoreaDepartment of Pharmaceutical Chemistry, Faculty of Pharmacy, Tanta University, Tanta, EgyptDepartment of Chemistry, Faculty of Science, University of Benghazi, Benghazi, LibyaDepartment of Pharmaceutics, Faculty of Pharmacy, Umm Al-Qura University, Makkah, Saudi ArabiaDepartment of Clinical Sciences, College of Medicine, University of Sharjah, Sharjah, the United Arab EmiratesDepartment of Pharmaceutical Chemistry, Faculty of Pharmacy, Kafrelsheikh University, Kafrelsheikh, EgyptPharmaceutical Chemistry Department, Faculty of Pharmacy, Ahram Canadian University, Giza, EgyptTopoisomerase II (TOP-2) is a promising molecular target for cancer therapy. Numerous antibiotics could interact with biologically relevant macromolecules and provoke antitumor potential. Herein, molecular docking studies were used to investigate the binding interactions of 138 antibiotics against the human topoisomerase II-DNA complex. Followed by the MD simulations for 200 ns and MM-GBSA calculations. On the other hand, the antitumor activities of the most promising candidates were investigated against three cancer cell lines using doxorubicin (DOX) as a reference drug. Notably, spiramycin (SP) and clarithromycin (CL) showed promising anticancer potentials on the MCF-7 cell line. Moreover, azithromycin (AZ) and CL exhibited good anticancer potentials against the HCT-116 cell line. Finally, the TOP-2 enzyme inhibition assay was carried out to confirm the proposed rationale. Briefly, potent TOP-2 inhibitory potentials were recorded for erythromycin (ER) and roxithromycin (RO). Additionally, a SAR study opened eyes to promising anticancer pharmacophores encountered by these antibiotics.https://www.tandfonline.com/doi/10.1080/14756366.2023.2171029Antibioticscytotoxicitytopoisomerase IImolecular docking and dynamicsMM-GBSA
spellingShingle Faten Farouk
Ayman Abo Elmaaty
Ahmed Elkamhawy
Haytham O. Tawfik
Radwan Alnajjar
Mohammed A. S. Abourehab
Mohamed A. Saleh
Wagdy M. Eldehna
Ahmed A. Al‐Karmalawy
Investigating the potential anticancer activities of antibiotics as topoisomerase II inhibitors and DNA intercalators: in vitro, molecular docking, molecular dynamics, and SAR studies
Journal of Enzyme Inhibition and Medicinal Chemistry
Antibiotics
cytotoxicity
topoisomerase II
molecular docking and dynamics
MM-GBSA
title Investigating the potential anticancer activities of antibiotics as topoisomerase II inhibitors and DNA intercalators: in vitro, molecular docking, molecular dynamics, and SAR studies
title_full Investigating the potential anticancer activities of antibiotics as topoisomerase II inhibitors and DNA intercalators: in vitro, molecular docking, molecular dynamics, and SAR studies
title_fullStr Investigating the potential anticancer activities of antibiotics as topoisomerase II inhibitors and DNA intercalators: in vitro, molecular docking, molecular dynamics, and SAR studies
title_full_unstemmed Investigating the potential anticancer activities of antibiotics as topoisomerase II inhibitors and DNA intercalators: in vitro, molecular docking, molecular dynamics, and SAR studies
title_short Investigating the potential anticancer activities of antibiotics as topoisomerase II inhibitors and DNA intercalators: in vitro, molecular docking, molecular dynamics, and SAR studies
title_sort investigating the potential anticancer activities of antibiotics as topoisomerase ii inhibitors and dna intercalators in vitro molecular docking molecular dynamics and sar studies
topic Antibiotics
cytotoxicity
topoisomerase II
molecular docking and dynamics
MM-GBSA
url https://www.tandfonline.com/doi/10.1080/14756366.2023.2171029
work_keys_str_mv AT fatenfarouk investigatingthepotentialanticanceractivitiesofantibioticsastopoisomeraseiiinhibitorsanddnaintercalatorsinvitromoleculardockingmoleculardynamicsandsarstudies
AT aymanaboelmaaty investigatingthepotentialanticanceractivitiesofantibioticsastopoisomeraseiiinhibitorsanddnaintercalatorsinvitromoleculardockingmoleculardynamicsandsarstudies
AT ahmedelkamhawy investigatingthepotentialanticanceractivitiesofantibioticsastopoisomeraseiiinhibitorsanddnaintercalatorsinvitromoleculardockingmoleculardynamicsandsarstudies
AT haythamotawfik investigatingthepotentialanticanceractivitiesofantibioticsastopoisomeraseiiinhibitorsanddnaintercalatorsinvitromoleculardockingmoleculardynamicsandsarstudies
AT radwanalnajjar investigatingthepotentialanticanceractivitiesofantibioticsastopoisomeraseiiinhibitorsanddnaintercalatorsinvitromoleculardockingmoleculardynamicsandsarstudies
AT mohammedasabourehab investigatingthepotentialanticanceractivitiesofantibioticsastopoisomeraseiiinhibitorsanddnaintercalatorsinvitromoleculardockingmoleculardynamicsandsarstudies
AT mohamedasaleh investigatingthepotentialanticanceractivitiesofantibioticsastopoisomeraseiiinhibitorsanddnaintercalatorsinvitromoleculardockingmoleculardynamicsandsarstudies
AT wagdymeldehna investigatingthepotentialanticanceractivitiesofantibioticsastopoisomeraseiiinhibitorsanddnaintercalatorsinvitromoleculardockingmoleculardynamicsandsarstudies
AT ahmedaalkarmalawy investigatingthepotentialanticanceractivitiesofantibioticsastopoisomeraseiiinhibitorsanddnaintercalatorsinvitromoleculardockingmoleculardynamicsandsarstudies